SE9904674D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9904674D0
SE9904674D0 SE9904674A SE9904674A SE9904674D0 SE 9904674 D0 SE9904674 D0 SE 9904674D0 SE 9904674 A SE9904674 A SE 9904674A SE 9904674 A SE9904674 A SE 9904674A SE 9904674 D0 SE9904674 D0 SE 9904674D0
Authority
SE
Sweden
Prior art keywords
novel compounds
compounds
directed
general formula
present application
Prior art date
Application number
SE9904674A
Other languages
English (en)
Swedish (sv)
Inventor
William Brown
Christopher Walpole
Original Assignee
Astra Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Inc filed Critical Astra Pharma Inc
Priority to SE9904674A priority Critical patent/SE9904674D0/xx
Publication of SE9904674D0 publication Critical patent/SE9904674D0/xx
Priority to KR1020077019022A priority patent/KR20070090050A/ko
Priority to PL00356780A priority patent/PL356780A1/xx
Priority to NZ519986A priority patent/NZ519986A/en
Priority to MXPA02006063A priority patent/MXPA02006063A/es
Priority to KR1020027007836A priority patent/KR100769814B1/ko
Priority to AU24184/01A priority patent/AU780799B2/en
Priority to BR0016591-3A priority patent/BR0016591A/pt
Priority to IL15012500A priority patent/IL150125A0/xx
Priority to UA2002064617A priority patent/UA71650C2/uk
Priority to EP00987916A priority patent/EP1242410B1/en
Priority to AT00987916T priority patent/ATE275143T1/de
Priority to RU2002114343/04A priority patent/RU2258703C2/ru
Priority to DE60013486T priority patent/DE60013486T2/de
Priority to PCT/SE2000/002562 priority patent/WO2001046174A1/en
Priority to SK883-2002A priority patent/SK8832002A3/sk
Priority to EEP200200337A priority patent/EE200200337A/xx
Priority to CZ20022124A priority patent/CZ20022124A3/cs
Priority to HU0300020A priority patent/HUP0300020A3/hu
Priority to CNA008190461A priority patent/CN1608064A/zh
Priority to PT00987916T priority patent/PT1242410E/pt
Priority to ES00987916T priority patent/ES2225289T3/es
Priority to CA002395300A priority patent/CA2395300A1/en
Priority to DK00987916T priority patent/DK1242410T3/da
Priority to US10/149,981 priority patent/US6680318B2/en
Priority to JP2001547084A priority patent/JP2003522741A/ja
Priority to SI200030501T priority patent/SI1242410T1/xx
Priority to ZA200204255A priority patent/ZA200204255B/en
Priority to BG106805A priority patent/BG65457B1/bg
Priority to IL150125A priority patent/IL150125A/en
Priority to NO20022920A priority patent/NO322432B1/no
Priority to IS6426A priority patent/IS2143B/is
Priority to HK03100216.5A priority patent/HK1048308B/zh
Priority to US10/714,448 priority patent/US20040138225A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Anesthesiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Furan Compounds (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Liquid Crystal (AREA)
SE9904674A 1999-12-20 1999-12-20 Novel compounds SE9904674D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9904674A SE9904674D0 (sv) 1999-12-20 1999-12-20 Novel compounds
SI200030501T SI1242410T1 (en) 1999-12-20 2000-12-15 Novel compounds
EEP200200337A EE200200337A (et) 1999-12-20 2000-12-15 Uued ühendid ning nende kasutamine
HU0300020A HUP0300020A3 (en) 1999-12-20 2000-12-15 Novel compounds
NZ519986A NZ519986A (en) 1999-12-20 2000-12-15 4[(4-substituted-1-piperazinyl)(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)methyl]-N,N-diethylbenzamide, pharmaceuticals thereof, and use thereof for treating pain, gastrointestinal disorders and spinal injuries
CZ20022124A CZ20022124A3 (cs) 1999-12-20 2000-12-15 Nové sloučeniny
KR1020027007836A KR100769814B1 (ko) 1999-12-20 2000-12-15 신규 화합물
AU24184/01A AU780799B2 (en) 1999-12-20 2000-12-15 Novel compounds
BR0016591-3A BR0016591A (pt) 1999-12-20 2000-12-15 Composto, uso de um composto, composição farmacêutica, e métodos para o tratamento da dor, de distúrbios gastrointestinais, e de danos na coluna vertebral
PL00356780A PL356780A1 (en) 1999-12-20 2000-12-15 Novel compounds
UA2002064617A UA71650C2 (uk) 1999-12-20 2000-12-15 Сполуки з аналгетичною дією, фармацевтична композиція на основі цих сполук та спосіб лікування
EP00987916A EP1242410B1 (en) 1999-12-20 2000-12-15 Novel compounds
AT00987916T ATE275143T1 (de) 1999-12-20 2000-12-15 Verbindungen
RU2002114343/04A RU2258703C2 (ru) 1999-12-20 2000-12-15 Новые соединения
DE60013486T DE60013486T2 (de) 1999-12-20 2000-12-15 Verbindungen
CNA008190461A CN1608064A (zh) 1999-12-20 2000-12-15 新化合物
SK883-2002A SK8832002A3 (en) 1999-12-20 2000-12-15 N-diarylmethylpiperazine derivatives, the use thereof and pharmaceutical compositions comprising same
KR1020077019022A KR20070090050A (ko) 1999-12-20 2000-12-15 신규 화합물
MXPA02006063A MXPA02006063A (es) 1999-12-20 2000-12-15 Compuestos novedosos.
IL15012500A IL150125A0 (en) 1999-12-20 2000-12-15 Novel compounds
PCT/SE2000/002562 WO2001046174A1 (en) 1999-12-20 2000-12-15 Novel compounds
PT00987916T PT1242410E (pt) 1999-12-20 2000-12-15 Compostos novos
ES00987916T ES2225289T3 (es) 1999-12-20 2000-12-15 Nuevos compuestos.
CA002395300A CA2395300A1 (en) 1999-12-20 2000-12-15 Novel compounds
DK00987916T DK1242410T3 (da) 1999-12-20 2000-12-15 Nye forbindelser
US10/149,981 US6680318B2 (en) 1999-12-20 2000-12-15 Piperazinomethylbenzamides as delta-opioid receptor agonists
JP2001547084A JP2003522741A (ja) 1999-12-20 2000-12-15 新規な化合物
ZA200204255A ZA200204255B (en) 1999-12-20 2002-05-28 Novel compounds.
BG106805A BG65457B1 (bg) 1999-12-20 2002-06-10 Пиперазинметил бензофуранови бензамиди, фармацевтичен състав, който ги съдържа, и тяхното използване като лекарствени средства
IL150125A IL150125A (en) 1999-12-20 2002-06-10 Compounds that react effectively with ઠ receptors and their use
NO20022920A NO322432B1 (no) 1999-12-20 2002-06-18 Nye forbindelser, deres anvendelse og farmasoytiske sammensetninger som omfatter de nye forbindelsene
IS6426A IS2143B (is) 1999-12-20 2002-06-18 Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni
HK03100216.5A HK1048308B (zh) 1999-12-20 2003-01-08 新化合物
US10/714,448 US20040138225A1 (en) 1999-12-20 2003-11-17 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904674A SE9904674D0 (sv) 1999-12-20 1999-12-20 Novel compounds

Publications (1)

Publication Number Publication Date
SE9904674D0 true SE9904674D0 (sv) 1999-12-20

Family

ID=20418210

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904674A SE9904674D0 (sv) 1999-12-20 1999-12-20 Novel compounds

Country Status (31)

Country Link
US (2) US6680318B2 (hu)
EP (1) EP1242410B1 (hu)
JP (1) JP2003522741A (hu)
KR (2) KR100769814B1 (hu)
CN (1) CN1608064A (hu)
AT (1) ATE275143T1 (hu)
AU (1) AU780799B2 (hu)
BG (1) BG65457B1 (hu)
BR (1) BR0016591A (hu)
CA (1) CA2395300A1 (hu)
CZ (1) CZ20022124A3 (hu)
DE (1) DE60013486T2 (hu)
DK (1) DK1242410T3 (hu)
EE (1) EE200200337A (hu)
ES (1) ES2225289T3 (hu)
HK (1) HK1048308B (hu)
HU (1) HUP0300020A3 (hu)
IL (2) IL150125A0 (hu)
IS (1) IS2143B (hu)
MX (1) MXPA02006063A (hu)
NO (1) NO322432B1 (hu)
NZ (1) NZ519986A (hu)
PL (1) PL356780A1 (hu)
PT (1) PT1242410E (hu)
RU (1) RU2258703C2 (hu)
SE (1) SE9904674D0 (hu)
SI (1) SI1242410T1 (hu)
SK (1) SK8832002A3 (hu)
UA (1) UA71650C2 (hu)
WO (1) WO2001046174A1 (hu)
ZA (1) ZA200204255B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
BR0209678A (pt) * 2001-05-18 2004-09-14 Astrazeneca Ab Composto, processo para preparar e uso do mesmo, composição farmacêutica, e, métodos para o tratamento da dor e de distúrbios gastrintestinais funcionais
EP1450807B1 (en) * 2001-10-29 2013-12-25 Versi Group, LLC Method of treating depression with delta receptor agonist compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0301441D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
US7196100B2 (en) 2003-12-12 2007-03-27 Eli Lilly And Company Opioid receptor antagonists
SE0400027D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
DK1781631T3 (da) 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
EP1856076A1 (en) * 2005-02-28 2007-11-21 AstraZeneca AB Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
GB0606876D0 (en) * 2006-04-05 2006-05-17 Glaxo Group Ltd Compounds
US20090291966A1 (en) * 2008-05-20 2009-11-26 Astrazeneca Ab Method Of Treating Anxious Major Depressive Disorder

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585209A5 (hu) 1973-06-29 1977-02-28 Cermol Sa
DE2900810A1 (de) 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it) 1980-05-23 1986-10-10 Selvi & C Spa 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en) 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
IT1196150B (it) 1984-06-19 1988-11-10 Poli Ind Chimica Spa Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv) 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en) 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en) 1987-04-24 1989-05-09 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en) 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
ATE102831T1 (de) 1989-11-22 1994-04-15 Janssen Pharmaceutica Nv Verfahren zur verhuetung oder zur begrenzung einer reperfusionsschaedigung.
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5807858A (en) 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
FR2696744B1 (fr) 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
DK0711289T3 (da) 1993-07-30 2000-11-06 Delta Pharmaceuticals Inc Piperazinforbindelser til anvendelse i terapi
JP3352184B2 (ja) 1993-11-12 2002-12-03 株式会社アズウェル ピペラジン不飽和脂肪酸誘導体
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
US5693843A (en) * 1995-12-22 1997-12-02 E. I. Du Pont De Nemours And Company Process for hydrocyanation of diolefins and isomerization of nonconjugated 2 alkyl-3-monoalkenenitriles
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
ES2251121T3 (es) 1997-12-24 2006-04-16 Ortho-Mcneil Pharmaceutical, Inc. (4)-aril(piperidin-4-il) aminobenzamidas que se unen al receptor opioide delta.
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds

Also Published As

Publication number Publication date
HUP0300020A3 (en) 2005-02-28
DK1242410T3 (da) 2004-11-29
NZ519986A (en) 2004-06-25
RU2258703C2 (ru) 2005-08-20
PL356780A1 (en) 2004-07-12
KR100769814B1 (ko) 2007-10-23
DE60013486D1 (de) 2004-10-07
BG65457B1 (bg) 2008-08-29
CN1608064A (zh) 2005-04-20
WO2001046174A1 (en) 2001-06-28
EP1242410A1 (en) 2002-09-25
BR0016591A (pt) 2002-09-10
SI1242410T1 (en) 2004-12-31
CA2395300A1 (en) 2001-06-28
JP2003522741A (ja) 2003-07-29
ES2225289T3 (es) 2005-03-16
BG106805A (en) 2003-03-31
KR20070090050A (ko) 2007-09-04
NO322432B1 (no) 2006-10-02
IS2143B (is) 2006-09-15
DE60013486T2 (de) 2005-11-17
US20030105110A1 (en) 2003-06-05
NO20022920L (no) 2002-07-22
AU780799B2 (en) 2005-04-21
IL150125A0 (en) 2002-12-01
ZA200204255B (en) 2003-08-28
KR20020062350A (ko) 2002-07-25
US20040138225A1 (en) 2004-07-15
MXPA02006063A (es) 2003-02-06
UA71650C2 (uk) 2004-12-15
PT1242410E (pt) 2004-12-31
EP1242410B1 (en) 2004-09-01
IL150125A (en) 2006-08-20
SK8832002A3 (en) 2003-03-04
IS6426A (is) 2002-06-18
RU2002114343A (ru) 2004-01-10
US6680318B2 (en) 2004-01-20
AU2418401A (en) 2001-07-03
HK1048308B (zh) 2005-04-08
CZ20022124A3 (cs) 2002-11-13
EE200200337A (et) 2003-10-15
NO20022920D0 (no) 2002-06-18
HUP0300020A2 (en) 2003-05-28
HK1048308A1 (en) 2003-03-28
ATE275143T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
DE69907977D1 (de) Pyrrolobenzodiazepine
SE0101387D0 (sv) Novel compounds
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
SE9904674D0 (sv) Novel compounds
SE9604786D0 (sv) New compounds
AP2001002318A0 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
IT1285770B1 (it) Composti corticoidei
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE326209T1 (de) Verminderung des haarwuchses
NO20002218D0 (no) Anvendelse av mirtazepin for behandling av søvnapne
SE9903290D0 (sv) Novel compounds
DK1294732T3 (da) Ruthenium (II)-forbindelser til anvendelse i cancerterapi
CY1105373T1 (el) Ισοκινολινυλικα καρβοξαμιδια και η χρηση τους ως αντισπαστικα
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
UY26102A1 (es) Derivados de 1-aminoetilindol, su preparación y su aplicación en terapéutica
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte
SE9802207D0 (sv) Novel compounds
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3
FI991138A0 (fi) Normobarisen hypoksian käyttö terapeuttisesti